Table 5.
Elevated BP prevalence ratios
| Sex | Age Group (yr) | Patients with Observed Elevated BP, n/n (%) | Prevalence in General Population (%) | Prevalence Ratio (95% CI) |
|---|---|---|---|---|
| Male | 0–19 | 32/390 (8.2) | 2.0 | 4.10 (0.78–21.61) |
| Female | 0–19 | 22/302 (7.3) | 1.0 | 7.29 (0.56–95.24) |
| Male | 20–29 | 65/267 (24.3) | 17.0 | 1.44 (0.88–2.32) |
| Female | 20–29 | 32/213 (15.0) | 5.0 | 3.00 (1.21–7.45)a |
| Male | 30–39 | 28/74 (37.8) | 16.0 | 2.36 (1.49–3.76)a |
| Female | 30–39 | 10/65 (15.4) | 10.0 | 1.54 (0.74–3.21) |
| Male | 40–49 | 5/10 (50.0) | 34.0 | 1.47 (0.76–2.82) |
| Female | 40–49 | 2/7 (28.6) | 31.0 | 0.92 (0.28–3.04) |
Comparison of the age- and sex-specific elevated BP prevalences with prevalences in the normal population. CI, confidence interval.
a
P<0.05.